Yongjian Wu

9PUBLICATIONS
26CO-AUTHORS
AllergyCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 01, 2026
Type 2 diabetes impairs macrophage antimicrobial capability and increases susceptibility to sepsis.

Mei Zhang, Yuanqing Zeng, Xingyu Li

|Feb 20, 2026
Engineered nanovesicles as a DC vaccine to enhance the antitumor efficacy of CAR-T cells against solid tumors.

Shaolong Ju, Tianchuan Zhu, Shoudeng Chen

|Nov 24, 2025
TREM2 Drives Neutrophil Extracellular Traps-Induced Dendritic Cell Maturation and Contributes to Lupus Progression.

Jingxian Shu, Jiabi Liang, Linda Zeng

|Apr 10, 2025
Inflammatory CD11c+ B Cells Induced by the TREM2 Signal Accelerate Sepsis Development.

Siqi Ming, Zhenxing Chen, Jingwen Yang

|May 31, 2024
Multifunctional Bispecific Nanovesicles Targeting SLAMF7 Trigger Potent Antitumor Immunity.

Manman Zhu, Yongjian Wu, Tianchuan Zhu

|Mar 12, 2022
TLT-1 Promotes Platelet-Monocyte Aggregate Formation to Induce IL-10-Producing B Cells in Tuberculosis.

Manni Wang, Xingyu Li, Qiaohua Wang

Pageof 2